DexCom, Inc. (DXCM)
90.06
-1.00
(-1.10%)
USD |
NASDAQ |
Sep 01, 16:00
90.06
0.00 (0.00%)
After-Hours: 16:13
DexCom Research and Development Expense (Annual) : 594.90M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 594.90M |
| December 31, 2024 | 545.70M |
| December 31, 2023 | 497.70M |
| December 31, 2022 | 484.20M |
| December 31, 2021 | 604.20M |
| December 31, 2020 | 359.90M |
| December 31, 2019 | 273.50M |
| December 31, 2018 | 412.00M |
| December 31, 2017 | 176.20M |
| December 31, 2016 | 156.10M |
| December 31, 2015 | 137.50M |
| December 31, 2014 | 69.40M |
| December 31, 2013 | 42.30M |
| Date | Value |
|---|---|
| December 31, 2012 | 39.50M |
| December 31, 2011 | 30.75M |
| December 31, 2010 | 23.23M |
| December 31, 2009 | 14.29M |
| December 31, 2008 | 19.63M |
| December 31, 2007 | 16.13M |
| December 31, 2006 | 19.42M |
| December 31, 2005 | 25.50M |
| December 31, 2004 | 12.18M |
| December 31, 2003 | 8.935M |
| December 31, 2002 | 6.311M |
| December 31, 2001 | 5.039M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Abbott Laboratories | 2.889B |
| Insulet Corp. | 301.10M |
| Baxter International, Inc. | 503.00M |
| Globus Medical, Inc. | 146.94M |
| Stryker Corp. | 1.567B |